Zenith® LP Abdominal Aortic Aneurysm (AAA) Post-Market Registry

Zenith® LP AAA Endovascular Graft Post-Market Registry

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01424267

Enrollment

Registered

2011-08-26

Start date

2010-07-31

Completion date

2012-08-31

Last updated

2012-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm, Aorto-iliac Aneurysm

Keywords

low profile, endovascular graft, endovascular procedure, aortic aneurysm, abdominal aortic aneurysm

Brief summary

A registry to collect additional prospective intra-operative and follow-up information on physician use of the CE-marked Zenith® Low Profile Abdominal Aortic Aneurysm (AAA) Endovascular Graft under routine clinical care.

Interventions

DEVICEZenith® Low Profile AAA Endovascular Graft

Treatment of an abdominal aortic or aorto-iliac aneurysm with the CE-marked Zenith(R) Low Profile AAA Endovascular Graft.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patient is implanted with Zenith® Low Profile AAA Endovascular Graft

Exclusion criteria

* Patients for whom this device would not normally be considered standard of care.

Design outcomes

Primary

Measure	Time frame
graft patency and aneurysm exclusion	during (day 1) and after implantation through 12 months

Countries

Austria, Germany, Ireland, Italy, Netherlands, Norway, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026